Who is sponsoring NCT03890549?

NCT03890549 is sponsored by Chang Gung Memorial Hospital.

What drugs are being tested in NCT03890549?

Interventions in NCT03890549: SnoreLab (smart phone application for snoring recording).

What condition does NCT03890549 study?

NCT03890549 studies Apnea, Obstructive, Snoring.

Is NCT03890549 still recruiting?

NCT03890549 is currently status unknown. Last updated 26 March 2019.

Last reviewed 2019-03-26 · How we verify

NCT03890549

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Validation of Downloadable Mobile Snore Applications by Polysomnography (PSG)

Status unknown Last updated 26 March 2019

What this trial tests

trial testing SnoreLab (smart phone application for snoring recording) in Apnea, Obstructive in 100 participants. Status unknown.

Timeline

1 April 2019

Primary endpoint
31 August 2020

1 December 2020

Quick facts

Lead sponsor	Chang Gung Memorial Hospital
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	100
Start date	1 April 2019
Primary completion	31 August 2020
Estimated completion	1 December 2020
Sites	1 location across Taiwan

Drugs / interventions tested

SnoreLab (smart phone application for snoring recording)

Conditions studied

Apnea, Obstructive — all drugs for Apnea, Obstructive →
Snoring — all drugs for Snoring →

Sponsor

Chang Gung Memorial Hospital

Who can join

Adults 20 to 80, any sex, with Apnea, Obstructive or Snoring. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to validate the downloadable mobile snore applications by polysomnography.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Validation of Downloadable Mobile Snore Applications by Polysomnography (PSG).
Shiao YH, Yu CC, Yeh YC. · · 2024 · cited 3× · PMID 38800087 · DOI 10.2147/nss.s433351

Verify or expand the search:

Other recruiting trials for Apnea, Obstructive

Currently open trials in the same condition.

NCT06462287 — EFFECT OF A SUBSTANCE P ANTAGONIST ON THE SECRETION OF ALDOSTERONE IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA SYNDROME AND · Phase 2 · recruiting
NCT04950894 — Treating Obstructive Sleep Apnea Using Targeted Hypoglossal Neurostimulation · NA · active not recruiting
NCT04179188 — Impact of Bariatric Surgery in Obese Patients With and Without Obstructive Sleep Apnea Syndrome · recruiting

Other Chang Gung Memorial Hospital trials

Trials by the same sponsor.

NCT07419789 — Precision Care for Older Persons · NA · not yet recruiting
NCT07248345 — Virtual Reality Intervention for Family Caregivers of Persons Living With Dementia · NA · not yet recruiting
NCT07036978 — Metabolomic and Immune-Microbiome Profiling for Unresectable Pancreatic Cancer · not yet recruiting
NCT07489833 — Metabolomic Pathways and Traditional Chinese Medicine Body Constitution in Cancer-related Fatigue · not yet recruiting
NCT07496528 — The ACURE Trial: Acupuncture for Colorectal Recovery · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03890549 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Chang Gung Memorial Hospital
Last refreshed: 26 March 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03890549.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing